Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients-Reference-Cited by-同舟云学术

Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients

Published:2004-11 Issue:9 Volume:36 Page:2679-2682
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Babel N.,Schwarzmann F.,Pruss A.,Volk H.-D.,Reinke P.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference14 articles.

1. The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance;Gregersen;Haematologica,2001

2. A long-term study of prognosis in monoclonal gammopathy of undetermined significance;Kyle;N Engl J Med,2002

3. Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder;Badley;Liver Transpl Surg,1996

4. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: Implications for understanding their pathogenesis and developing rational treatment strategies;Hanto;Annu Rev Med,1995

5. Association between Epstein-Barr virus infection and late acute transplant rejection in long-term transplant patients;Babel;Transplantation,2001

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geographic Prevalence Patterns and Modifiable Risk Factors for Monoclonal Gammopathy of Undetermined Significance;Hemato;2023-11-01

2. Characterization of monoclonal gammopathy of undetermined significance progression to multiple myeloma through meta-analysis of GEO data;Heliyon;2023-07

3. The Role of the Crosstalk Between Gut Microbiota and Immune Cells in the Pathogenesis and Treatment of Multiple Myeloma;Frontiers in Immunology;2022-03-31

4. Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma;Frontiers in Immunology;2022-01-11

5. Monoclonal Gammopathies with Miscellaneous Associations;Paraproteinemia and Related Disorders;2022